Mr. Jeong serves as as Chief Financial Officer of AVEO Oncology, an LG Chem company. Mr. Jeong joins AVEO from its parent company, LG Chem, Ltd. (“LG Chem”), where he has served as a financial and accounting officer since 1999. During his time at LG Chem, Mr. Jeong has served as the financial director and
Matthew Horsman serves as as Senior Controller of AVEO Oncology, an LG Chem company. With an accounting career spanning over 25 years, Mr. Horsman has held various accounting roles across multiple industries. Prior to joining AVEO’s management team, he served as the Controller for Enzyvant Therapeutics, Inc. During Mr. Horsman’s time at Enzyvant, he oversaw
Danielle Holland serves as Senior Vice President, General Counsel and Corporate Secretary of AVEO Oncology, an LG Chem company. Prior to joining AVEO, Ms. Holland served as an Associate at Skadden, Arps, Slate, Meagher & Flom LLP where she advised public and private clients in a variety of industries in corporate and securities law matters, mergers
Barbara Fielman has more than 25 years of experience in the pharmaceutical industry, and rejoins AVEO Oncology, an LG Chem company, as Senior Vice President of Clinical Operations and Medical Science Liaisons. Ms. Fielman most recent experiences include her leading the clinical operations teams at Hookipa Pharma, Inc. and Sumitomo Pharma America (formerly Sumitomo Pharma
Mr. Ferraresso, who joined AVEO Oncology, an LG Chem company, in December 2017, most recently served as senior vice president, business analytics and commercial operations. He has over 20 years of commercial pharmaceutical and biotechnology experience, including 15 years developing and commercializing oncology products. At AVEO, in addition to developing the Company’s commercial strategy and
Bob Fedak serves as the Vice President of Information Technology at AVEO Oncology, an LG Chem company. With an Information Technology career spanning over 20 years, Mr. Fedak brings his extensive experience in building and leading highly engaged information technology teams, while ensuring a company’s information technology contributes to a positive work experience for all
Reetu Dandora serves as Vice President, Compliance and Regulatory Counsel at AVEO Oncology, an LG Chem company, and brings over 25 years of counseling clients in the pharmaceutical and health care industries on a wide array of business initiatives. Prior to joining AVEO, Ms. Dandora worked at Merck & Co., Inc. (“Merck”), in two separate
David Crist brings more than twenty years of oncology sales experience in both launch-stage and late-stage companies, building commercial organizations and developing high performing sales force teams. During his career, Mr. Crist held oncology-focused sales roles at several leading pharmaceutical companies including MGI (Molecular Genetics, Inc), Eisai, Sanofi Genzyme, GlaxoSmithKline and ARIAD Pharmaceuticals, where he
Jonathan Briggs serves as Vice President of Quality Assurance at AVEO Oncology, an LG Chem company, bringing over 35 years of industry experience, including 26 years in quality management. Mr. Briggs most recently served as Vice President of Quality Assurance at Genocea Biosciences, Inc. (Genocea), a biopharmaceutical company developing T-cell immunotherapies targeting solid tumors. Prior
Dr. Edgar Braendle serves as Chief Medical Officer of AVEO Oncology, an LG Chem company. Dr. Braendle is a life sciences executive bringing over 20 years of experience spanning from early drug discovery to the launch of small molecules, biologics, radiopharmaceuticals, gene and cell therapies, and medical device development. Dr. Braendle most recently served as